Federal Court of Appeal dismisses appeal of first trial decision under the amended PMNOC Regulations

Published date25 November 2020
Subject MatterPatents,Appeals,Obviousness,Dismissals,Biosimilars,Pfizer,Patent Litigation,Pharmaceutical Patents,Amgen,Canada,Amended Regulation,Health Canada,PMNOC Regulations
AuthorUrszula Wojtyra
Law FirmSmart & Biggar

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT